In vitro efficacy of diclofenac against Listeria monocytogenes
- 105 Downloads
Chemotherapy is often futile in systemic listeriosis, translating to being a peril to public health. There is, thus, an imperative need for novel antilisterial compounds, possibly acting through mechanisms dissimilar to those of existing drugs. The present study describes one such agent—the non-steroidal anti-inflammatory drug (NSAID) diclofenac sodium (Dc). The National Committee for Clinical Laboratory Standards (NCCLS) minimum inhibitory concentration (MIC), mode of action, and two mechanisms of action, i.e., on bacterial DNA and membrane, have been characterized with respect to Dc. The drug showed noteworthy inhibitory action (MIC90 = 50 μg/ml) against Listeria strains, demonstrated cidal (minimum bactericidal concentration [MBC]=100 μg/ml) activity, inhibited listerial DNA synthesis (45.48%; incorporation of [methyl-3H] thymidine), and possessed bacterial membrane-damaging activity (37.33%; BacLight assay). Dc could be used as a lead compound for the synthesis of new, more active agents perhaps devoid of side effects. Further, quantitative structure–activity relationship (QSAR) studies will contribute to a new generation of promising adjuvants to existing antilisterial drugs.
KeywordsMinimum Inhibitory Concentration Blood Stream Infection Listeriosis Agar Dilution Method Antilisterial Activity
This work was supported by grants provided by the Korea Research Foundation and the Brain Korea 21 project, South Korea.
Transparency declarations: none to declare.
- 2.Kristiansen JE (1991) Antimicrobial activity of non-antibiotics. ASM News 57(3):135–139Google Scholar
- 4.Nelson KE, Fouts DE, Mongodin EF, Ravel J, DeBoy RT, Kolonay JF, Rasko DA, Angiuoli SV, Gill SR, Paulsen IT, Peterson J, White O, Nelson WC, Nierman W, Beanan MJ, Brinkac LM, Daugherty SC, Dodson RJ, Durkin AS, Madupu R, Haft DH, Selengut J, Van Aken S, Khouri H, Fedorova N, Forberger H, Tran B, Kathariou S, Wonderling LD, Uhlich GA, Bayles DO, Luchansky JB, Fraser CM (2004) Whole genome comparisons of serotype 4b and 1/2a strains of the food-borne pathogen Listeria monocytogenes reveal new insights into the core genome components of this species. Nucleic Acids Res 32(8):2386–2395PubMedCrossRefGoogle Scholar
- 5.Washington JA 2nd, Sutter VL (1980) Dilution susceptibility test: agar and macro-broth dilution procedures. In: Lennette EH, Balows A, Hausler WJ, Truant JP (eds) Manual of clinical microbiology, 3rd ed. American Society for Microbiology, Washington, DC, pp 453–458Google Scholar
- 6.National Committee for Clinical Laboratory Standards (NCCLS) (2003) Methods for dilution in antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard M7-A6 and MIC testing supplemental tables M100-S13, 6th edn, vol 23, no 2. NCCLS, Wayne, PAGoogle Scholar
- 7.Krogstad DJ, Moellering RC (1980) Combinations of antibiotics, mechanisms of interaction against bacteria. In: Lorian V (ed), Antibiotics in laboratory medicine. Lippincott Williams & Wilkins, Baltimore, London, p 305Google Scholar
- 8.Robards AW, Wilson AJ (1993) Basic biological preparation techniques for TEM. In: Procedures in electron microscopy. Wiley, Chichester, United Kingdom, p 84Google Scholar